N-ACETYLTRANSFERASE 2 GENE POLYMORPHISM IS A POSSIBLE BIOMARKER OF LUNG CANCER RISK IN YAKUT POPULATION


  • E.V. Tsypandina Yakut Scientific Center of Complex Medical Problems, Russia
  • E.K. Rumyantsev Yakut Scientific Center of Complex Medical Problems, Russia
  • V.M. Nikolaev Yakut Scientific Center of Complex Medical Problems, Russia
Keywords: lung cancer, polymorphic variant, N-acetyltransferase-2 (NAT2)

Abstract

N-ACETYLTRANSFERASE 2 GENE POLYMORPHISM IS A POSSIBLE BIOMARKER OF LUNG CANCER RISK IN YAKUT POPULATION

References

1. Clinical pharmacogenetics. / Sychev D.A. [et al.] edited by V.G. Kukis, N.P. Bochkova. – M.: Geotar-Media, 2007. – P.248.

2. Ravegnini G, Sammarini G, Hrelia P, Angelini S. Key Genetic and Epigenetic Mechanisms in Chemical Carcinogenesis. Toxicol Sci. 2015 Nov;148(1):2-13. doi:10.1093/toxsci/kfv165.

3. Antonova O, Toncheva D, Grigorov E. Bladder cancer risk from the perspective of genetic polymorphisms in the carcinogen metabolizing enzymes. J BUON. 2015 Nov-Dec;20(6):1397-406.

4. Wang S, Hao J, Wang H, Fang Y, Tan L. Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer. Oncoimmunology. 2018 Apr 24;7(8):e1457600. doi: 10.1080/2162402X.2018.1457600.

5. Kim AS, Ko HJ, Kwon JH, Lee JM. Exposure to Secondhand Smoke and Risk of Cancer in Never Smokers: A Meta-Analysis of Epidemiologic Studies. Int J Environ Res Public Health. 2018 Sep 11;15(9). pii: E1981. doi: 10.3390/ijerph15091981.

6. Eckhardt M, Zhang W, Gross AM, Von Dollen J, Johnson JR, Franks-Skiba KE, Swaney DL, Johnson TL, Jang GM, Shah PS, Brand TM, Archambault J, Kreisberg JF, Grandis JR, Ideker T, Krogan NJ. Multiple Routes to Oncogenesis are Promoted by the Human Papillomavirus-Host Protein Network. Cancer Discov. 2018 Sep 12. pii: CD-17-1018. doi: 10.1158/2159- 8290.CD-17-1018.

7. Ju J, Chen A, Deng Y, Liu M, Wang Y, Wang Y, Nie M, Wang C, Ding H, Yao B, Gui T, Li X, Xu Z, Ma C, Song Y, Kvansakul M, Zen K, Zhang CY, Luo C, Fang M, Huang DCS, Allis CD, Tan R, Zeng CK, Wei J, Zhao Q. NatD promotes lung cancer progression by preventing histone H4 serine phosphorylation to activate Slug expression. Nat Commun. 2017 Oct 13;8(1):928. doi:10.1038/s41467-017-00988-5.

8. Fayez D, Saliminejad K, Irani S, Kamali K, Memariani T, Khorram Khorshid HR. Arylamine N-acetyltransferase 2 Polymorphisms and the Risk of Endometriosis. Avicenna J Med Biotechnol. 2018 Jul-Sep;10(3):163-167.

9. Wang Y, Wang Z, Xu J, Li J, Li S, Zhang M, Yang D. Systematic identification of non-coding pharmacogenomic landscape in cancer. Nat Commun. 2018 Aug 9;9(1):3192. doi: 10.1038/s41467-018-05495-9.

10. Hwang IW, Kim K, Kwon BN, Kim HJ, Han SH, Lee NR, Choi EJ, Cho HI, Jin HJ. Association of glutathione S-transferase M1 and T1 null/present polymorphism with physical performance in the Korean population. Genes Genomics. 2018 Sep 10. doi: 10.1007/s13258-018-0737-6.
Published
2018-11-15
How to Cite
Tsypandina, E., Rumyantsev, E., & Nikolaev, V. (2018). N-ACETYLTRANSFERASE 2 GENE POLYMORPHISM IS A POSSIBLE BIOMARKER OF LUNG CANCER RISK IN YAKUT POPULATION. Biological Markers in Fundamental and Clinical Medicine (collection of Abstracts), 2(2), 79-80. https://doi.org/10.29256/v.02.02.2018.escbm70
Section
Selected abstracts